Reimbursement policy and androgen-deprivation therapy for prostate cancer

Keyphrases

• 95% Confidence Interval 20%
• Adjuvant Androgen Deprivation Therapy 10%
• Adjuvant Therapy 20%
• American Cancer Society 10%
• Androgen Deprivation Therapy 100%
• Evidence-based 10%
• High-grade Tumor 10%
• Inappropriate Use 20%
• Localized Cancer 10%
• Locally Advanced Cancer 10%
• Low-to-moderate 10%
• Medicare Database 10%
• Medicare Modernization Act 10%
• Medicare Reimbursement 10%
• Modified Poisson Regression 10%
• Odds Ratio 20%
• Poisson Regression Model 10%
• Primary Therapy 20%
• Prostate Cancer 100%
• Radiation Therapy 10%
• Reimbursement 10%
• Reimbursement Mechanisms 100%
• Substantial Change 10%
• Surveillance Epidemiology 10%
• Survival Benefit 20%
• Year of Diagnosis 20%

Nursing and Health Professions

• Adjuvant Therapy 18%
• Advanced Cancer 9%
• Androgen Deprivation Therapy 100%
• Confidence Interval 18%
• Epidemiology 9%
• Medicare 27%
• Odds Ratio 18%
• Prostate Cancer 100%
• Radiotherapy 9%
• Reimbursement 100%

Medicine and Dentistry

• Adjuvant Therapy 18%
• Advanced Cancer 9%
• Androgen Deprivation Therapy 100%
• Cancer 9%
• Malignant Neoplasm 9%
• Medicare 27%
• Odds Ratio 18%
• Prostate Cancer 100%
• Radiation Therapy 9%
• Surveillance, Epidemiology, and End Results 9%
• Tumor 9%